Skip to main content
Log in

A Stability-Indicating LC Assay and Degradation Behavior of Temozolomide Drug Substances

  • Limited Short Communication
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

This study deals with a stability indicating HPLC reverse phase method for quantitative determination of temozolomide. A chromatographic separation was achieved on an Inertsil ODS 3V, 250 × 4.6 mm ID, 5 μm column using mobile phase A (buffer 5 mL glacial acetic acid in 1,000 mL of Milli Q water ) and mobile phase B (methanol). Forced degradation studies were performed on bulk sample of temozolomide using acid (0.5 N hydrochloric acid), base (0.5 N sodium hydroxide), oxidation (10% v/v hydrogen peroxide), heat (60 °C) and UV light (254 nm). Degradation of the drug substance was observed in base hydrolysis and oxidation. Degradation product formed under these conditions was found to be Imp-A. When the stress samples were assayed, the mass balance was close to 99.5%. The sample solution was stable up to 48 h at 5 °C and mobile phase was found to be stable up to 48 h at 25 °C. The developed method was validated with respect to linearity, accuracy, precision, robustness and forced degradation studies prove the stability indicating power of the method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Ueno T, Ko SH, Grubbs E, Pruitt SK, Friedman HS, Tyler DS (2004) Am J Surg 188:532–537

    Article  CAS  Google Scholar 

  2. Basso U, Ermani M, Reni M, Vastola F, Tosoni A, Pasetto LM, Coria B, Cacciacarne M, Sala F, Brandes AA (2003) Eur J Cancer 1:S95

    Google Scholar 

  3. Intensive and Critical Care Nursing (2000) 16:59–60

  4. Siker ML, Chakravarti A, Mehta MP (2006) Crit Rev Oncol/Hematol 60:99–111

    Article  Google Scholar 

  5. Giorgio CG, Giuffrida D, Pappalardo A, Russo A, Santini D, Salice P, Blanco G, Castorina S, Failla G, Bordonaro R (2005) Lung Cancer 50:247–254

    Article  Google Scholar 

  6. International conference on harmonization October (1994), Text on Validation of Analytical Procedures Q2A

  7. Kim H, Likhari P, Parker D, Statkevich P, Marco A, Lin CC, Nomeir AA (2001) J Pharm Biomed Anal 24:461–468

    Article  CAS  Google Scholar 

  8. Chowdhury SK, Laudicina D, Blumenkrantz N, Wirth M, Alton KB (1999) J Pharm Biomed Anal 19:659–668

    Article  CAS  Google Scholar 

  9. Kim HK, Lin CC, Parker D, Veals J, Lim J, Likhari P, Statkevich P, Marco A, Nomeir AA (1997) J Chromatogr B: Biomed Sci Appl 703:225–233

    Article  CAS  Google Scholar 

  10. International conference on harmonization November (1996), Validation of analytical procedures methodology Q2B

Download references

Acknowledgments

The authors wish to thank the management of Dr. Reddy’s group for supporting this work. Authors wish to acknowledge the process research group for providing the samples for our research. We would also like to thank colleagues in the separation science division of the Analytical Research of High Potent Active Pharmaceutical Ingredients for their co-operation in carrying out this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Saravanan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saravanan, G., Ravikumar, M., Jadhav, M.J. et al. A Stability-Indicating LC Assay and Degradation Behavior of Temozolomide Drug Substances. Chroma 66, 291–294 (2007). https://doi.org/10.1365/s10337-007-0306-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1365/s10337-007-0306-7

Keywords

Navigation